PF-06256142

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

PF-06256142

Specification
Cat. No.
SMD1656
Related Diseases
Schizophrenia
Product Name
PF-06256142
Size
Customizable
Price
Inquiry
Description
PF-06256142 is a potent and selective orthosteric agonist of the D1 receptor with D1 EC50=30 nM and D1 binding Ki = 12 nM. PF-06256142 may be useful for treatment of Parkinson’s disease (PD) and schizophrenia. PF-06256142 has reduced receptor desensitization relative to dopamine and other catechol-containing agonists. PF-06256142 has the (+)-Enantiomer with [α]20/D = +35.2 (c 0.32, CH2Cl2). The pharmacokinetic properties of PF-06256142 such as metabolic stability, high passive permeability, and low MDR and BCRP efflux ratios make this compound suitable for oral dosing and in vivo study.
CAS Number
1609583-14-3 (rotation +)
Chemical Formula
C21H16N4O2
Exact Mass
356.1273
Molecular Weight
356.385
Elemental Analysis
C, 70.77; H, 4.53; N, 15.72; O, 8.98
Synonym
PF-06256142; PF 06256142; PF06256142;
IUPAC/Chemical Name
(+)-4-(3-Methyl-4-(6-methylimidazo[1,2-a]pyrazin-5-yl)phenoxy)furo[3,2-c]-pyridine
InChi Key
HWAIAGZSWHOLLK-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H16N4O2/c1-13-11-15(27-21-17-6-10-26-18(17)5-7-23-21)3-4-16(13)20-14(2)24-12-19-22-8-9-25(19)20/h3-12H,1-2H3
SMILES Code
CC1=CC(OC2=NC=CC3=C2C=CO3)=CC=C1C4=C(N=CC5=NC=CN45)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.03.00
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top